NEUVÉ Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: a broad catalog of GLP-1, hormone and peptide protocols under one brand
NEUVÉ Health scores highest on the strength of its clinical program — drug options and dosing support.
What the plan covers
Medication
Not disclosed
Provider visits
Not disclosed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
NEUVÉ Health (neuvemd.com) is a physician-led telehealth brand offering compounded GLP-1 weight-loss protocols alongside hormone optimization, peptides, men's health and lab panels. Its public pricing page advertises GLP-1 from $138 a month, but the real plans appear only after a completed intake and start at $160. The figures are billed every 28 days rather than monthly, and the site contradicts itself over whether the medication is included in them.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to NEUVÉ Health
Editorial score · methodology
Try Ageless
Best for: lowest-tier compounded GLP-1 in injection, troche and sublingual forms
Editorial score · methodology
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
NEUVÉ Health at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $160/mo (Program fee. Site contradicts itself on whether medication is included.)
- Pricing model
- Scales with dose — higher doses cost more
- FDA status
- No FDA warning letter on record
How we scored NEUVÉ Health
Each dimension is scored algorithmically from NEUVÉ Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.8/10NEUVÉ Health does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit. Note the price scales with dose, so budget for higher tiers as you titrate.
Effectiveness25%
7.9/10NEUVÉ Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.6/10Online intake and platform experience; 1 platform feature disclosed.
Trust & Safety15%
6.7/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-17).
Accessibility10%
5.8/10NEUVÉ Health's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.6/10NEUVÉ Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this NEUVÉ Health review
Last checked August 2026- Confirmed current pricing across 3 dose/plan tiers
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with NEUVÉ Health
We walked NEUVÉ Health’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Land on /pricing, which shows one starting figure per program line: GLP-1 from $138/mo, hormone therapy from $127/mo, peptides from $137/mo, labs from $45.
- 2Select Unlock full pricing or Find your plan in 3 minutes to see per-protocol figures.
- 3An email address is requested at this point; the full price list is not shown before it.
- Only starting floors are public. The page is titled Transparent pricing, for members, and the members qualifier is doing real work.
- Recorded as after-intake because that is the closest available value: a from floor IS shown before intake, but the price a patient would actually pay is only available after one, and the enum has no option for partial.
- The personal-data gate appears at the very first step, on the pricing page itself, rather than deep in an intake.
- Site states no consultation fee, no insurance games, and no charge until a licensed clinician approves your plan.
- All prescribing decisions are stated to be made by a US licensed clinician after intake.
- Walk stopped at the email field: no account created, no personal or health data entered.
GLP-1 medications NEUVÉ Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Program fee. Site contradicts itself on whether medication is included.
Program fee. Site contradicts itself on whether medication is included.
Recommended plan at intake. Program fee; medication billed separately per fine print.
Ready to get started?
Plans and promotions change often — check NEUVÉ Health's current pricing and active discounts before you decide.
What we like
- Shows three named plans with prices immediately after intake, rather than making you create an account first
- States that there is no consultation fee and no charge until a licensed clinician approves the plan
- Broad catalog beyond GLP-1s — hormone therapy, peptides, men's health and lab panels under one brand
- Editorial guides on its own site name the molecules and compare them rather than only selling
Watch-outs
- Contradicts itself on whether medication is included — the fine print says billed separately, the What-s Included panel says included
- The advertised from $138/mo matches no real plan — the cheapest option after intake is $160
- States served are not enumerated anywhere on the site
- No dispensing pharmacy named and no LegitScript badge displayed
- Billed every 28 days, not monthly — 13 charges a year, and payment can precede the final questionnaire or lab visit
Is NEUVÉ Health worth it? Our verdict
NEUVÉ Health positions itself around one thing: a broad catalog of GLP-1, hormone and peptide protocols under one brand. Its standout is a needle-free oral option, which very few providers offer.
How much NEUVÉ Health actually costs
NEUVÉ Health doesn't post a standard monthly cash price publicly. Start a consultation to get an exact quote, and confirm the ongoing rate — not just any first-month offer — before you commit.
Medications: what NEUVÉ Health prescribes
NEUVÉ Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
NEUVÉ Health's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who NEUVÉ Health is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
NEUVÉ Health could be worth a look, but it doesn't publish a standard price up front — get a quote and confirm the ongoing rate before deciding, and compare it against the alternatives below. If you're comparison-shopping, Sesame Care is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
NEUVÉ Health scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with NEUVÉ Health?
See current pricing and start your free consultation.
NEUVÉ Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this NEUVÉ Health review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See NEUVÉ Health's current pricing
Start your free consultation to check eligibility and today's price.